1. Home
  2. NVAX vs DHC Comparison

NVAX vs DHC Comparison

Compare NVAX & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$12.78

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Logo Diversified Healthcare Trust of Beneficial Interest

DHC

Diversified Healthcare Trust of Beneficial Interest

N/A

Current Price

$7.56

Market Cap

1.8B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
NVAX
DHC
Founded
1987
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
1996
1998

Fundamental Metrics

Financial Performance
Metric
NVAX
DHC
Price
$12.78
$7.56
Analyst Decision
Buy
Buy
Analyst Count
9
5
Target Price
★ $14.00
$10.15
AVG Volume (30 Days)
★ 6.6M
1.4M
Earning Date
11-05-2026
11-02-2026
Dividend Yield
N/A
★ 0.53%
EPS Growth
★ 309.76
23.23
EPS
N/A
★ N/A
Revenue
★ $1,123,479,000.00
$1,074,819,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.00
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 64.69
1.59
52 Week Low
$6.20
$3.93
52 Week High
$13.39
$9.66

Technical Indicators

Market Signals
Indicator
NVAX
DHC
Relative Strength Index (RSI) 68.95 38.15
Support Level $7.64 $7.42
Resistance Level N/A $7.59
Average True Range (ATR) 0.97 0.23
MACD 0.11 -0.03
Stochastic Oscillator 85.02 21.91

Price Performance

Historical Comparison
NVAX
DHC

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.

Share on Social Networks: